Literature DB >> 34711915

Transplant indications, guidelines and recommendations: Caveat Emptor.

Robert Peter Gale1, Giovanni Barosi2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34711915     DOI： 10.1038/s41409-021-01510-8

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

1.  A model for validating an expert's opinion in medical negligence cases.

Authors:  Howard Smith
Journal:  J Leg Med       Date:  2005-06

Review 2.  Comparing efficacy of reduced-toxicity allogeneic hematopoietic cell transplantation with conventional chemo-(immuno) therapy in patients with relapsed or refractory CLL: a Markov decision analysis.

Authors:  M A Kharfan-Dabaja; J Pidala; A Kumar; T Terasawa; B Djulbegovic
Journal:  Bone Marrow Transplant       Date:  2012-05-07       Impact factor: 5.483

3.  Being certain even when you're wrong: heuristics and thin slicing in haematopoietic cell transplantation.

Authors:  Robert Peter Gale
Journal:  Bone Marrow Transplant       Date:  2020-12-08       Impact factor: 5.483

4.  Markov model of CLL transplants.

Authors:  R P Gale
Journal:  Bone Marrow Transplant       Date:  2012-09       Impact factor: 5.483

5.  Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy.

Authors:  Abraham S Kanate; Navneet S Majhail; Bipin N Savani; Christopher Bredeson; Richard E Champlin; Stephen Crawford; Sergio A Giralt; Charles F LeMaistre; David I Marks; James L Omel; Paul J Orchard; Jeanne Palmer; Wael Saber; Paul A Veys; Paul A Carpenter; Mehdi Hamadani
Journal:  Biol Blood Marrow Transplant       Date:  2020-03-09       Impact factor: 5.742

6.  Abandonment of high-dose chemotherapy/hematopoietic cell transplants for breast cancer following negative trial results.

Authors:  David H Howard; Carolyn Kenline; Hillard M Lazarus; Charles F Lemaistre; Richard T Maziarz; Philip L McCarthy; Susan K Parsons; David Szwajcer; James Douglas Rizzo; Navneet S Majhail
Journal:  Health Serv Res       Date:  2011-07-25       Impact factor: 3.402

7.  Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019.

Authors:  Rafael F Duarte; Myriam Labopin; Peter Bader; Grzegorz W Basak; Chiara Bonini; Christian Chabannon; Selim Corbacioglu; Peter Dreger; Carlo Dufour; Andrew R Gennery; Jürgen Kuball; Arjan C Lankester; Francesco Lanza; Silvia Montoto; Arnon Nagler; Régis Peffault de Latour; John A Snowden; Jan Styczynski; Ibrahim Yakoub-Agha; Nicolaus Kröger; Mohamad Mohty
Journal:  Bone Marrow Transplant       Date:  2019-04-05       Impact factor: 5.483

8.  Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.

Authors:  Sergio A Giralt; Charles F LeMaistre; Navneet S Majhail; Stephanie H Farnia; Paul A Carpenter; Richard E Champlin; Stephen Crawford; David I Marks; James L Omel; Paul J Orchard; Jeanne Palmer; Wael Saber; Bipin N Savani; Paul A Veys; Christopher N Bredeson
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-07       Impact factor: 5.742
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.